These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 18486144)
1. Crystal structures of human 108V and 108M catechol O-methyltransferase. Rutherford K; Le Trong I; Stenkamp RE; Parson WW J Mol Biol; 2008 Jun; 380(1):120-30. PubMed ID: 18486144 [TBL] [Abstract][Full Text] [Related]
2. The 108M polymorph of human catechol O-methyltransferase is prone to deformation at physiological temperatures. Rutherford K; Bennion BJ; Parson WW; Daggett V Biochemistry; 2006 Feb; 45(7):2178-88. PubMed ID: 16475806 [TBL] [Abstract][Full Text] [Related]
4. Functional and structural comparisons of cysteine residues in the Val108 wild type and Met108 variant of human soluble catechol O-methyltransferase. Li Y; Yang X; Chang M; Yager JD; van Breemen RB; Bolton JL Chem Biol Interact; 2005 Apr; 152(2-3):151-63. PubMed ID: 15840388 [TBL] [Abstract][Full Text] [Related]
5. Crystal structures of the apo and holo form of rat catechol-O-methyltransferase. Tsuji E; Okazaki K; Isaji M; Takeda K J Struct Biol; 2009 Mar; 165(3):133-9. PubMed ID: 19111934 [TBL] [Abstract][Full Text] [Related]
6. G/A1947 polymorphism in catechol-O-methyltransferase (COMT) gene in Parkinson's disease. Xie T; Ho SL; Li LS; Ma OC Mov Disord; 1997 May; 12(3):426-7. PubMed ID: 9159741 [TBL] [Abstract][Full Text] [Related]
9. Equine catechol estrogen 4-hydroxyequilenin is a more potent inhibitor of the variant form of catechol-O-methyltransferase. Li Y; Yao J; Chang M; Nikolic D; Yu L; Yager JD; Mesecar AD; van Breemen RB; Bolton JL Chem Res Toxicol; 2004 Apr; 17(4):512-20. PubMed ID: 15089093 [TBL] [Abstract][Full Text] [Related]
10. L-dopa upregulates the expression and activities of methionine adenosyl transferase and catechol-O-methyltransferase. Zhao WQ; Latinwo L; Liu XX; Lee ES; Lamango N; Charlton CG Exp Neurol; 2001 Sep; 171(1):127-38. PubMed ID: 11520127 [TBL] [Abstract][Full Text] [Related]
11. Comparative study of ortho- and meta-nitrated inhibitors of catechol-O-methyltransferase: interactions with the active site and regioselectivity of O-methylation. Palma PN; Rodrigues ML; Archer M; Bonifácio MJ; Loureiro AI; Learmonth DA; Carrondo MA; Soares-da-Silva P Mol Pharmacol; 2006 Jul; 70(1):143-53. PubMed ID: 16618795 [TBL] [Abstract][Full Text] [Related]
12. Characterization of two new variants of human catechol O-methyltransferase in vitro. Li Y; Yang X; van Breemen RB; Bolton JL Cancer Lett; 2005 Dec; 230(1):81-9. PubMed ID: 16253764 [TBL] [Abstract][Full Text] [Related]
13. Crystal structures of rat catechol-O-methyltransferase complexed with coumarine-based inhibitor. Tsuji E; Okazaki K; Takeda K Biochem Biophys Res Commun; 2009 Jan; 378(3):494-7. PubMed ID: 19056347 [TBL] [Abstract][Full Text] [Related]
15. Design of electrochemical biosensor systems for the detection of specific DNA sequences in PCR-amplified nucleic acids related to the catechol-O-methyltransferase Val108/158Met polymorphism based on intrinsic guanine signal. Ozkan-Ariksoysal D; Tezcanli B; Kosova B; Ozsoz M Anal Chem; 2008 Feb; 80(3):588-96. PubMed ID: 18181582 [TBL] [Abstract][Full Text] [Related]
16. Molecular recognition at the active site of catechol-O-methyltransferase (COMT): adenine replacements in bisubstrate inhibitors. Ellermann M; Paulini R; Jakob-Roetne R; Lerner C; Borroni E; Roth D; Ehler A; Schweizer WB; Schlatter D; Rudolph MG; Diederich F Chemistry; 2011 May; 17(23):6369-81. PubMed ID: 21538606 [TBL] [Abstract][Full Text] [Related]